FDA approves Sanofi's Sarclisa Escena, first anticancer treatment adm…

FDA approves Sarclisa Escena, a subcutaneous formulation of Sanofi's multiple myeloma drug administered via Enable Injections' on-body injector, matching IV efficacy with shorter treatment time and fewer infusion-related reactions. If you're building drug-delivery devices, pharma giants now need you to solve the patient experience problem they've ignored for decades. Sanofi just proved that a simpler injector beats IV infusions on efficacy and comfort—that's a commercial template for every high-volume cancer therapy on the market.